MedTrace Logo

Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study

NCT06355830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-04-09

No results posted yet for this study

Summary

Study: observational prospective clinical study. Study population: Subjects over 55 years old with drusen secondary to intermediate AMD.

Recruitment: at the Medical Retinal Consultation from the Ophthalmology Department of CHULC.

Primary outcome: Identifying imaging predictors of iAMD progression.

Conditions

  • Age-Related Macular Degeneration

Interventions

DIAGNOSTIC_TEST

Orthoptic assessment (Outcome measure)

The protocol image assessment is non-invasive and includes retinal imaging by Color Fundus photography (CFP), Spectral Domain Optical Coherence Tomography (SD-OCT), OCT-Angiography (OCT-A) using Spectralis OCT, with OCT Angiography Module (Heidelberg Eng. GmbH, Germany).

Sponsors & Collaborators

  • iNOVA4Health, NOVA Medical School|Faculdade de Ciências Médicas, NMS|FCM, UNL

    collaborator UNKNOWN

  • Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal

    collaborator UNKNOWN

  • Centro Hospitalar De São João, E.P.E.

    collaborator OTHER

  • Universidade Nova de Lisboa

    lead OTHER

Principal Investigators

  • Rita Flores, MD · Centro Hospitalar Universitário de Lisboa Central, iNOVA4Health Nova Medical School, Universidade Nova de Lisboa

  • Sandra Tenreiro, PhD · iNOVA4Health Nova Medical School, Universidade Nova de Lisboa

Eligibility

Min Age
55 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2025-06-30
Completion
2026-06-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06355830 on ClinicalTrials.gov